Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 21Other hematologic neoplasm 12Dermatologic 4Thoracic 2Other solid neoplasm 1Myeloid 1Gynecologic 1Breast 1

Conditions

Mesothelioma, Malignant 57Mesothelioma 35Unspecified Adult Solid Tumor, Protocol Specific 25Solid Tumor 9Advanced Solid Tumors 8Advanced Solid Tumor 7Solitary Fibrous Tumor, Pleural 6Carcinoma, Non-Small-Cell Lung 6Sarcoma 4Lung Neoplasms 4Solid Tumors 3Peritoneal Neoplasms 3Neoplasms 3Stomach Neoplasms 2Retinoblastoma 2Prostatic Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Head and Neck Neoplasms 2Extensive Stage Small Cell Lung Cancer 2Colorectal Neoplasms 2Colonic Neoplasms 2Central Nervous System Neoplasms 2Breast Neoplasms 2Advanced Solid Tumour 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1

Interventions

tazemetostat 2ruxolitinib 1entinostat 1avelumab 1Rifampin 1Polymerase Chain Reaction 1Pemetrexed 1Microarray Analysis 1Itraconazole 1Immunoenzyme Techniques 1Gene Expression Profiling 1Flow Cytometry 1Fentanyl 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Cisplatin × Other solid neoplasm × Clear all
NCT04328844 2026-03-30

A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

iOnctura

Phase 1 Active not recruiting
210 enrolled
DermatologicLymphoidMyeloidOther solid neoplasmThoracic

Uveal Melanoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Mesothelioma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡